© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists
ORIGINAL ARTICLE
HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques
1 Department of Cytogenetics, Sheffield Genetics Services, Sheffield Childrens NHS Trust, Western Bank, Sheffield S10 2TH, UK
2 Department of Histopathology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2SF, UK
Correspondence to:
Correspondence to:
Dr E L Maltby
Department of Cytogenetics, Sheffield Genetics Services, Sheffield Childrens NHS Trust, Western Bank, Sheffield S10 2TH, UK; Edna.Maltby{at}sheffch-tr.trent.nhs.uk
Aims: To compare the results of breast cancer sections with HercepTestTM immunohistochemistry (IHC) scores ranging from 0 to 3+ with fluorescence in situ hybridisation (FISH) for HER2 amplification. The HER2 digital scoring application of the Micrometastasis Detection System (MDSTM) was used, together with manual scoring of FISH and HercepTest, to determine whether this system provides an accurate alternative.
Methods: Paraffin wax embedded sections were stained using HercepTest and analysed by eye and automated quantitative image analysis. FISH was performed using the PathVysionTM fluorescent probe and scored by eye and automated quantitative image analysis using MDS.
Results: Of 114 cases, 26% were amplified by FISH, whereas only 18% scored 3+; 32% of IHC 2+ cases were amplified by FISH, and one showed borderline amplification. Six percent of IHC negative cases (0 or 1+) were amplified by FISH, and one showed borderline amplification. Of IHC 3+ cases, 10% were non-amplified by FISH. Classification discrepancies were seen in 18% of HercepTest cases scored by eye and using the MDS system. MDS was consistent with visual FISH scoring and correctly differentiated most ambiguous visual IHC scores.
Conclusions: FISH provides a more accurate and consistent scoring system for determining HER2 amplification than HercepTest. The MDS system provides a reliable, consistent alternative to visual IHC and FISH scoring. IHC is still a valuable technique to aid in identification of isolated or heterogeneous tumour populations for subsequent FISH analysis, and a combined FISH and HercepTest approach to all breast cancer cases may be the most efficient strategy.
Abbreviations: DDW, double distilled water; FISH, fluorescence in situ hybridisation; IHC, immunohistochemistry; MDS, Micrometastasis Detection System
Keywords: FISH; HER2; breast cancer; Herceptin; immunohistochemistry
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Sauter, G., Lee, J., Bartlett, J. M.S., Slamon, D. J., Press, M. F.
(2009). Reply to V. Arena et al. JCO
27: e9-e10
[Full Text] -
Zustin, J, Boddin, K, Tsourlakis, M C, Burandt, E, Mirlacher, M, Jaenicke, F, Izbicki, J, Ruether, W, Rueger, J M, Bokemeyer, C, Simon, R, Sauter, G
(2009). HER-2/neu analysis in breast cancer bone metastases. J. Clin. Pathol.
62: 542-546
[Abstract] [Full Text] -
Walker, R A, Bartlett, J M S, Dowsett, M, Ellis, I O, Hanby, A M, Jasani, B, Miller, K, Pinder, S E
(2008). HER2 testing in the UK: further update to recommendations. J. Clin. Pathol.
61: 818-824
[Abstract] [Full Text] -
Arnould, L., Arveux, P., Couturier, J., Gelly-Marty, M., Loustalot, C., Ettore, F., Sagan, C., Antoine, M., Penault-Llorca, F., Vasseur, B., Fumoleau, P., Coudert, B. P.
(2007). Pathologic Complete Response to Trastuzumab-Based Neoadjuvant Therapy Is Related to the Level of HER-2 Amplification. Clin. Cancer Res.
13: 6404-6409
[Abstract] [Full Text] -
Kroese, M., Zimmern, R. L, Pinder, S. E
(2007). HER2 status in breast cancer--an example of pharmacogenetic testing. JRSM
100: 326-329
[Abstract] [Full Text] -
Dallard, B. E., Ruffino, V., Heffel, S., Calvinho, L. F.
(2007). Effect of a Biological Response Modifier on Expression of Growth Factors and Cellular Proliferation at Drying Off. J DAIRY SCI
90: 2229-2240
[Abstract] [Full Text] -
Stevens, R., Almanaseer, I., Gonzalez, M., Caglar, D., Knudson, R. A., Ketterling, R. P., Schrock, D. S., Seemayer, T. A., Bridge, J. A.
(2007). Analysis of HER2 Gene Amplification Using an Automated Fluorescence in Situ Hybridization Signal Enumeration System. J. Mol. Diagn.
9: 144-150
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
